Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abacavir Effect on Platelet Activation in HIV
NCT01886638Phase 4Completed
- Start
- Aug 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abacavir in human immunodeficiency virus infection (HIV). Primary endpoint: Phosphorylated Vasodilator Stimulated Phosphoprotein at Day 48. Started Aug 2013; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01886638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886638.